GLYMPSE BIO

glympse-bio-logo

Glympse Bio develops a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The companyโ€™s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bioโ€™s platform technology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering.

#SimilarOrganizations #People #Financial #Event #Website #More

GLYMPSE BIO

Social Links:

Industry:
Biotechnology Health Care Life Science Medical Device Nanotechnology

Founded:
2015-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.glympsebio.com

Total Employee:
11+

Status:
Active

Contact:
617-863-3636

Email Addresses:
[email protected]

Total Funding:
93.3 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Font Awesome


Similar Organizations

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

demetrix-logo

Demetrix

Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.

flare-therapeutics-logo

Flare Therapeutics

Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.

lunapbc-logo

LunaPBC

LunaPBC is a healthcare company that transforms health data into health breakthroughs.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.


Current Advisors List

stanley-lapidus_image

Stanley Lapidus Board Chairman @ Glympse Bio
Board_member
2018-09-01

sangeeta-bhatia_image

Sangeeta Bhatia Co-Founder & Chair of Scientific Advisory Board @ Glympse Bio
Advisor
2015-12-01

amy-schulman_image

Amy Schulman Board of Directors @ Glympse Bio
Board_member

steven-j-kafka_image

Steven J. Kafka Board Member @ Glympse Bio
Board_member
2020-07-01

george-zachary_image

George Zachary Board Member @ Glympse Bio
Board_member
2020-07-01

andrew-perlman_image

Andrew Perlman Board Observer @ Glympse Bio
Board_observer
2020-07-01

theresia-gouw_image

Theresia Gouw Board of Directors @ Glympse Bio
Board_member

Current Employees Featured

matthew-navarro_image

Matthew Navarro
Matthew Navarro Chief Financial Officer @ Glympse Bio
Chief Financial Officer

gabe-kwong_image

Gabe Kwong
Gabe Kwong Co-Founder @ Glympse Bio
Co-Founder

caroline-loew_image

Caroline Loew
Caroline Loew President & Chief Executive Officer @ Glympse Bio
President & Chief Executive Officer

jonathan-wilde_image

Jonathan Wilde
Jonathan Wilde Chief Scientific Officer @ Glympse Bio
Chief Scientific Officer
2022-05-01

tram-tran_image

Tram Tran
Tram Tran Chief Medical Officer @ Glympse Bio
Chief Medical Officer

Founder


gabe-kwong_image

Gabe Kwong

sangeeta-bhatia_image

Sangeeta Bhatia

Investors List

temasek_image

Temasek Holdings

Temasek Holdings investment in Series B - Glympse Bio

new-leaf-venture-partners_image

New Leaf Venture Partners

New Leaf Venture Partners investment in Series B - Glympse Bio

ls-polaris-innovation-fund_image

LS Polaris Innovation Fund

LS Polaris Innovation Fund investment in Series B - Glympse Bio

crvvc_image

CRV

CRV investment in Series B - Glympse Bio

catalio-capital-management_image

Catalio Capital Management

Catalio Capital Management investment in Series B - Glympse Bio

gilead-sciences_image

Gilead Sciences

Gilead Sciences investment in Series B - Glympse Bio

greatpoint-ventures_image

GreatPoint Ventures

GreatPoint Ventures investment in Series B - Glympse Bio

section-32_image

Section 32

Section 32 investment in Series B - Glympse Bio

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series B - Glympse Bio

dns-capital_image

DNS Capital

DNS Capital investment in Series B - Glympse Bio

Official Site Inspections

http://www.glympsebio.com Semrush global rank: 5.51 M Semrush visits lastest month: 1.55 K

  • Host name: 233.151.226.35.bc.googleusercontent.com
  • IP address: 35.226.151.233
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Glympse Bio" on Search Engine